Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,902.00    16.00 (0.85%)
Bid:
1,910.00
Ask:
1,911.00
Spread: 1.00 (0.052%)
Market Cap: £3.19b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

16 Apr 2018 07:25

RNS Number : 9451K
Johnson Matthey PLC
16 April 2018
 

Johnson Matthey Plc announces Patrick Thomas as Chairman Designate

 

The Board of Directors of Johnson Matthey Plc is pleased to announce that Patrick Thomas will succeed Tim Stevenson as Chairman.

 

Patrick will join the board as Non-Executive Director and Chairman Designate on 1st June 2018. He will be appointed as Chairman of the board with effect from the end of the Annual General Meeting on 26th July 2018 when Tim Stevenson retires, after seven years as Chairman.

 

Patrick has deep experience in leading international speciality chemicals businesses. He brings to Johnson Matthey an impressive track record of driving growth through science and innovation across global markets. Since 2015 Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a world leading polymers business. Between 2007 and 2015 he was also Chief Executive Officer of its predecessor, Bayer MaterialScience, prior to its demerger from Bayer AG. Patrick will step down from his role at Covestro AG at the end of May 2018.

 

Before joining Bayer, Patrick spent five years with the global chemical company, Huntsman Corporation, including as President of its Polyurethanes, Performance and Advanced Materials divisions. Prior to this he was Chief Executive of ICI’s polyurethanes business and led its integration into Huntsman. In his earlier career, Patrick held a number of global and regional roles in ICI.

 

Patrick also has strong board experience. He is currently an independent non-executive director of Akzo Nobel N.V., the paints, coating and specialty chemicals group. He was previously an independent non-executive director and member of the Audit and Remuneration Committees of BG Group plc from December 2010 to February 2016.

 

Patrick’s background is in Engineering Science; he has an MA from Oxford University, is a Fellow of the Royal Academy of Engineering and a Fellow of the Institute of Engineering and Technology.

 

Commenting on Patrick’s appointment, Tim Stevenson, Chairman of Johnson Matthey, said:

 

"I am thrilled that the board has chosen Patrick to succeed me as Chairman. Patrick brings a valuable combination of extensive board experience and recent executive leadership of major global organisations. I am confident that he will successfully steer Johnson Matthey to deliver continued value for our shareholders as we pursue our vision to make the world a cleaner and healthier place."

 

Robert MacLeod, Chief Executive of Johnson Matthey, added:

 

"I am delighted to welcome Patrick as the future Chairman of Johnson Matthey and look forward to working with him as we deliver our growth strategy."

 

Commenting on his appointment, Patrick Thomas said:

 

“I am really excited to be joining Johnson Matthey, a company with a strong reputation for science and a great team of people. I am looking forward to joining the board as we continue to evolve and grow, creating value for our shareholders and for the world around us.”

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years):

 

Patrick was appointed as a non-executive director and member of the supervisory board of Akzo Nobel N.V. in November 2017, a company listed on the stock exchange of Euronext Amsterdam.

 

Since August 2015, Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a company listed on the Frankfurt Stock Exchange.

 

From December 2010 to February 2016, Patrick was a non-executive director of BG Group Plc, a company listed on the London Stock Exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

 

 

 

Analysts and investors:

 

Martin Dunwoodie

+44 (0)20 7269 8241

Simon McGough

+44 (0)20 7269 8235

Katharine Burrow

+44 (0)20 7269 8444

 

 

Media:

 

Sally Jones

+44 (0)20 7269 8407

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDLKRGRZG
Date   Source Headline
19th Feb 20252:24 pmRNSHolding(s) in Company
13th Feb 20254:35 pmRNSDirector/PDMR Shareholding - replacement
13th Feb 20254:21 pmRNSDirector/PDMR Shareholding
13th Feb 202511:19 amRNSDirector/PDMR Shareholding
12th Feb 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSBoard Changes
7th Feb 202510:15 amRNSDirector/PDMR Shareholding
6th Feb 20254:26 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSDelivering strategic objectives to drive value
27th Jan 20257:00 amRNSEstablishment of Investment Committee
23rd Jan 20254:47 pmRNSHolding(s) in Company
23rd Jan 20251:36 pmRNSDirector/PDMR Shareholding
22nd Jan 202510:13 amRNSHolding(s) in Company
15th Jan 20255:12 pmRNSHolding(s) in Company
8th Jan 20258:35 amRNSResponse to Letter from Standard Investments
7th Jan 20257:00 amRNSHolding(s) in Company
3rd Jan 20254:46 pmRNSHolding(s) in Company
31st Dec 20249:00 amRNSTotal Voting Rights
27th Dec 20248:07 amRNSHolding(s) in Company
23rd Dec 20244:21 pmRNSHolding(s) in Company
19th Dec 20243:10 pmRNSDirector/PDMR Shareholding
18th Dec 20243:17 pmRNSHolding(s) in Company
18th Dec 20243:08 pmRNSHolding(s) in Company
16th Dec 20244:36 pmRNSHolding(s) in Company
16th Dec 20244:06 pmRNSHolding(s) in Company
16th Dec 20241:13 pmRNSResponse to letter from Standard Investments
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:19 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTotal Voting Rights
9th Dec 20243:24 pmRNSHolding(s) in Company
9th Dec 20243:17 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20243:33 pmRNSHolding(s) in Company
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20244:39 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20244:41 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20242:00 pmRNSTotal Voting Rights
29th Nov 20247:00 amRNSHolding(s) in Company
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20244:19 pmRNSDirector/PDMR Shareholding
28th Nov 20249:54 amRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20245:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.